Parkon as a treatment of the Parkinson’s disease

The application of the advancements in biophysics and biochemistry in medical science received a new impulse in the recent years. One of them was the discovery of superoxide radicals [1], in the inhaled atmospheric air and the vital role of this radical [2]. New views regarding the vital role of exogenous Reactive Oxygen Species (ROS) were developed [3]. ROS that enter the organism through the inhalation and regulate a series of vital functions receive most of the attention.

• Publication year

  2019

• Venue

  Open Journal of Parkinson's Disease and Treatment

• Publication date

  2019-03-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.17352/OJPDT.000006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood-brain barrier unlocked

  2012cited by this paper
• Reactive Oxygen Species as Essential Components of Ambient Air

  2002cited by this paper
• Is Atmospheric Superoxide Vitally Necessary? Accelerated Death of Animals in a Quasi-Neutral Electric Atmosphere

  1997cited by this paper
• [The vomeronasal system].

  1996cited by this paper
• Exogenous gaseous superoxide potentiates the antinociceptive effect of opioid analgesic agents

  1996cited by this paper
• Negative air ions as a source of superoxide

  1992cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Mesolimbic dopamine release elicited by activation of the accessory olfactory system: a high speed chronoamperometric study.

  1992cited by this paper
• Parkinson's Disease and Movement Disorders

  1990cited by this paper
• Parkinsonism

  1967cited by this paper

• The results of a clinical and neurophysiological study of the effectiveness of Parkon spray in the treatment of Parkinson’s Disease (PD)

  2022cites this paper
• How does medicine Parkon® affect the MPTP-induced oxidation stress and MAO systems of the rats brain

  2021cites this paper
• Parkon® in the treatment of multiple sclerosis. A pilot study

  2020cites this paper